ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

No Constitutional Right To Experimental Drugs, Appeals Court Rules Against Abigail Alliance.

August 10, 2007

Surgical Oncology Status A Disaster, DCT board Told; Kramer Describes Radiotherapy Needs

April 20, 1979

ACR Survey Finds Radiologist Change Mammography Methods

April 3, 1987

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980